ESAs Rosetta will be the first mission to orbit and land on a comet, one of the icy bodies that travel throughout the Solar System and develop a characteristic tail when they approach the Sun. Rosetta is scheduled to be launched on-board an Ariane-5 rocket in January 2003 from Kourou, French Guiana. A decision on the launch date will be taken by Tuesday 14 January (see Arianespace press release N° 03/02 of 7 January 2003 or at http:www.arianespace.com).
The mission’s target is Comet Wirtanen and the encounter will occur in 2011. Rosetta’s name comes from the famous Rosetta stone, that almost 200 years ago led to the deciphering of Egyptian hieroglyphics. In a similar way, scientists hope that the Rosetta spacecraft will unlock the mysteries of the Solar System.
Comets are very interesting objects for scientists, since their composition reflects how the Solar System was when it was very young and still unfinished, more than 4600 million years ago. Comets have not changed much since then. By orbiting Comet Wirtanen and landing on it, Rosetta will collect essential information to understand the origin and evolution of our Solar System. It will also help discover whether comets contributed to the beginnings of life on Earth. In fact comets are carriers of complex organic molecules, that - delivered to Earth through impacts – perhaps played a role in the origin of living forms. Furthermore, volatile light elements carried by comets may have also played an important role in forming the Earth’s oceans and atmopshere.
A special elemental magic
28.05.2020 | Kyoto University
Elucidation of nanostructures in practical heterogeneous catalysts
28.05.2020 | Japan Advanced Institute of Science and Technology
In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".
Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...
Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.
researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...
Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.
When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...
Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.
Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...
Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.
A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...
19.05.2020 | Event News
07.04.2020 | Event News
06.04.2020 | Event News
28.05.2020 | Transportation and Logistics
28.05.2020 | Physics and Astronomy
28.05.2020 | Power and Electrical Engineering